HUE065029T2 - Compositions and methods related to diagnosis of prostate cancer - Google Patents
Compositions and methods related to diagnosis of prostate cancerInfo
- Publication number
- HUE065029T2 HUE065029T2 HUE15768735A HUE15768735A HUE065029T2 HU E065029 T2 HUE065029 T2 HU E065029T2 HU E15768735 A HUE15768735 A HU E15768735A HU E15768735 A HUE15768735 A HU E15768735A HU E065029 T2 HUE065029 T2 HU E065029T2
- Authority
- HU
- Hungary
- Prior art keywords
- diagnosis
- compositions
- prostate cancer
- methods related
- methods
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Evolutionary Biology (AREA)
- Primary Health Care (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Bioethics (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461972099P | 2014-03-28 | 2014-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE065029T2 true HUE065029T2 (en) | 2024-04-28 |
Family
ID=54196462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE15768735A HUE065029T2 (en) | 2014-03-28 | 2015-03-27 | Compositions and methods related to diagnosis of prostate cancer |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US11761962B2 (en) |
| EP (2) | EP3123381B1 (en) |
| JP (3) | JP6775488B2 (en) |
| KR (1) | KR102505543B1 (en) |
| CN (2) | CN106663149A (en) |
| AR (1) | AR099883A1 (en) |
| AU (1) | AU2015237270B2 (en) |
| BR (1) | BR112016022407A2 (en) |
| CA (1) | CA2944001C (en) |
| CL (1) | CL2016002419A1 (en) |
| DE (1) | DE202015009668U1 (en) |
| DK (1) | DK3123381T3 (en) |
| EA (1) | EA201691952A1 (en) |
| ES (1) | ES2964706T3 (en) |
| FI (1) | FI3123381T3 (en) |
| HU (1) | HUE065029T2 (en) |
| IL (2) | IL247981B (en) |
| MX (2) | MX2016012667A (en) |
| MY (1) | MY192513A (en) |
| PE (1) | PE20170298A1 (en) |
| PL (1) | PL3123381T3 (en) |
| PT (1) | PT3123381T (en) |
| SG (2) | SG10201808585TA (en) |
| TW (1) | TWI687688B (en) |
| WO (1) | WO2015148979A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008137008A2 (en) | 2007-05-04 | 2008-11-13 | Claros Diagnostics, Inc. | Fluidic connectors and microfluidic systems |
| DE202010018623U1 (en) | 2009-02-02 | 2018-12-07 | Opko Diagnostics, Llc | Structures for controlling the light interaction with microfluidic devices |
| KR101933752B1 (en) | 2012-03-05 | 2018-12-28 | 오와이 아크틱 파트너스 에이비 | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| US20170089904A1 (en) * | 2014-03-28 | 2017-03-30 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| HUE055020T2 (en) | 2015-03-27 | 2021-11-29 | Opko Diagnostics Llc | Prostate antigen standards and uses thereof |
| DK3359189T3 (en) * | 2015-10-05 | 2021-07-05 | Fredax Ab | HUMANIZED ANTI PSA (5A10) ANTIBODIES |
| WO2017100457A1 (en) | 2015-12-11 | 2017-06-15 | Opko Diagnostics, Llc | Fluidic systems involving incubation samples and/or reagents |
| JP6956719B2 (en) | 2015-12-29 | 2021-11-02 | オプコ・ダイアグノスティクス・リミテッド・ライアビリティ・カンパニーＯｐｋｏ Ｄｉａｇｎｏｓｔｉｃｓ，Ｌｌｃ | Goods for collecting fluids |
| AU2018205280A1 (en) * | 2017-01-08 | 2019-08-15 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Systems and methods for using supervised learning to predict subject-specific pneumonia outcomes |
| KR102052398B1 (en) | 2018-04-18 | 2019-12-05 | (주)유로테크 | Biomarkers for diagnosis of prostate cancer and uses thereof |
| WO2020205204A1 (en) | 2019-04-03 | 2020-10-08 | Opko Diagnostics, Llc | Methods for the detection of prostate cancer |
| KR102730255B1 (en) * | 2022-08-12 | 2024-11-15 | (주)맥시온 | Multiple Biomarkers for Cancer Diagnosis and Uses Thereof |
| CN118629514B (en) * | 2024-08-08 | 2024-10-29 | 上海橙帆医药有限公司 | Sequence immunogenicity prediction method, device, electronic device and storage medium |
Family Cites Families (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6176962B1 (en) | 1990-02-28 | 2001-01-23 | Aclara Biosciences, Inc. | Methods for fabricating enclosed microchannel structures |
| SE9002480D0 (en) | 1990-07-23 | 1990-07-23 | Hans Lilja | ASSAY OF FREE AND COMPLEXED PROSTATE-SPECIFIC ANTIGEN |
| EP0635575A1 (en) | 1993-07-22 | 1995-01-25 | Wallac Oy | Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen |
| US5516639A (en) | 1993-07-22 | 1996-05-14 | Mayo Foundation For Medical Education And Research | Antibodies specific for human prostate glandular kallkrein |
| KR960705501A (en) | 1993-10-28 | 1996-11-08 | 윌리암 모피트 | FLUID SAMPLE COLLECTION AND INTRODUCTION DEVICE |
| US5599677A (en) | 1993-12-29 | 1997-02-04 | Abbott Laboratories | Immunoassays for prostate specific antigen |
| US5585069A (en) | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
| US5614372A (en) | 1995-02-24 | 1997-03-25 | Lilja; Hans | Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1) |
| KR19990036069A (en) | 1995-08-03 | 1999-05-25 | 이.에이치. 리링크 | Diagnostic device |
| US6143509A (en) | 1996-02-06 | 2000-11-07 | Abbott Laboratories | Prostate specific antigen peptides and uses thereof |
| WO1997039351A1 (en) | 1996-04-12 | 1997-10-23 | Carter Herbert B | Novel methods for the prediction and early detection of prostatic adenocarcinoma |
| US5840501A (en) | 1996-10-25 | 1998-11-24 | Bayer Corporation | Determination of cPSA |
| US5945289A (en) | 1996-12-20 | 1999-08-31 | Lehrer; Steven | Method for detecting prostate cancer by apolipoprotein E (Apo-E) genotyping |
| US5842787A (en) | 1997-10-09 | 1998-12-01 | Caliper Technologies Corporation | Microfluidic systems incorporating varied channel dimensions |
| SE9704934D0 (en) | 1997-12-30 | 1997-12-30 | Pharmacia & Upjohn Diag Ab | Assay procedure with addition in two or more positions |
| FI980488A (en) | 1998-03-04 | 1999-09-05 | Arctic Partners Oy Ab | New diagnostic method |
| FR2780791B1 (en) | 1998-07-03 | 2000-09-01 | Bio Merieux | METHOD OF SCREENING OR DIAGNOSIS OF ADENOCARCINOMA OR BENIGN PROSTATE PATHOLOGY AND PROCESS FOR IMPLEMENTATION |
| EP1151142A2 (en) | 1999-01-28 | 2001-11-07 | Gen-Probe Incorporated | Nucleic acid sequences for detecting genetic markers for cancer in a biological sample |
| US6444425B1 (en) | 1999-04-02 | 2002-09-03 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
| US7211397B2 (en) | 1999-04-30 | 2007-05-01 | Beckman Coulter, Inc. | Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| US6136549A (en) | 1999-10-15 | 2000-10-24 | Feistel; Christopher C. | systems and methods for performing magnetic chromatography assays |
| FI20002127A0 (en) | 2000-09-27 | 2000-09-27 | Artic Partners Oy Ab | A new antibody, immunoassay, and method for detecting prostate cancer |
| US20020076825A1 (en) | 2000-10-10 | 2002-06-20 | Jing Cheng | Integrated biochip system for sample preparation and analysis |
| WO2002046448A2 (en) | 2000-11-20 | 2002-06-13 | Eastern Virginia Medical School | Methods and devices for the quantitative detection of prostate specific membrane antigen and other prostatic markers |
| US20040219163A1 (en) | 2001-10-03 | 2004-11-04 | Frelinger John G. | Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2 |
| EP1461606A4 (en) | 2001-12-05 | 2005-06-29 | Univ Washington | MICROFLUIDIC DEVICE AND SURFACE DECORATION METHOD FOR SOLID PHASE AFFINITY BINDING ASSAYS |
| US20030235816A1 (en) | 2002-03-14 | 2003-12-25 | Baylor College Of Medicine (By Slawin And Shariat) | Method to determine outcome for patients with prostatic disease |
| US20050272052A1 (en) | 2002-04-09 | 2005-12-08 | Affymetrix, Inc. | Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer |
| AU2003242389A1 (en) | 2002-05-28 | 2003-12-12 | Jokoh Co., Ltd | Immunological chromatograph method test slip reading/quantitative determination device |
| WO2004013609A2 (en) | 2002-08-06 | 2004-02-12 | The Johns Hopkins University | Use of biomarkers for detecting ovarian cancer |
| US20040115794A1 (en) | 2002-12-12 | 2004-06-17 | Affymetrix, Inc. | Methods for detecting transcriptional factor binding sites |
| JP4824540B2 (en) | 2003-02-07 | 2011-11-30 | ダイアノキュアー インク． | How to detect prostate cancer in a sample |
| US7461048B2 (en) | 2003-07-21 | 2008-12-02 | Aureon Laboratories, Inc. | Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition |
| US20060269971A1 (en) | 2003-09-26 | 2006-11-30 | Mount Sinai Hospital | Methods for detecting prostate cancer |
| EP1535667A1 (en) | 2003-11-28 | 2005-06-01 | Sysmex Corporation | Analyzer, assay cartridge and analyzing method |
| US20080107565A1 (en) | 2003-12-10 | 2008-05-08 | The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth | Modular Biochip Assembly |
| WO2005066613A1 (en) | 2003-12-31 | 2005-07-21 | President And Fellows Of Harvard College | Assay device and method |
| PL1776181T3 (en) | 2004-01-26 | 2014-03-31 | Harvard College | Fluid delivery system and method |
| US8030057B2 (en) | 2004-01-26 | 2011-10-04 | President And Fellows Of Harvard College | Fluid delivery system and method |
| TW200538734A (en) | 2004-03-12 | 2005-12-01 | Aureon Biosciences Corp | Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition |
| CA2564208A1 (en) * | 2004-05-11 | 2005-11-24 | Baylor College Of Medicine | Method to predict prostate cancer |
| US20060154276A1 (en) | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| KR20070043868A (en) | 2004-08-02 | 2007-04-25 | 칠드런'즈 메디컬 센터 코포레이션 | Platelet Biomarkers for Cancer |
| EP1802764A4 (en) | 2004-09-17 | 2010-02-03 | Univ Johns Hopkins | BIOLOGICAL MARKERS FOR BREAST CANCER |
| US8663600B2 (en) | 2005-02-17 | 2014-03-04 | Diaprost Ab | Diagnosis of prostate cancer |
| WO2006122312A2 (en) | 2005-05-11 | 2006-11-16 | The Trustees Of The University Of Pennsylvania | Methods of testing using a microfluidic cassette |
| US20070065954A1 (en) | 2005-09-15 | 2007-03-22 | Minoru Taya | Surface plasmon resonance biosensor system for detection of antigens and method for determining the presence of antigens |
| KR20090006837A (en) | 2006-03-24 | 2009-01-15 | 페노미넘 디스커버리스 인코포레이티드 | Blomarkers useful for diagnosing prostate cancer, and methods thereof |
| CN101506376A (en) | 2006-07-03 | 2009-08-12 | 埃克森希特医疗股份有限公司 | Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| CN1973778A (en) | 2006-12-08 | 2007-06-06 | 南京大学 | Method of predicting serious complication risk degree after gastric cancer operation |
| DK2106262T3 (en) | 2006-12-22 | 2016-02-15 | Phadia Ab | HOW TO UNKNOWN PROSTATA CALLICREEN ALLERGY |
| WO2008137008A2 (en) | 2007-05-04 | 2008-11-13 | Claros Diagnostics, Inc. | Fluidic connectors and microfluidic systems |
| JP2010528261A (en) * | 2007-05-08 | 2010-08-19 | ピコベラ・リミテッド・ライアビリティ・カンパニー | Diagnosis and treatment method for prostate cancer and lung cancer |
| CN101329343A (en) | 2007-06-19 | 2008-12-24 | 天津迪爱盟生物技术有限公司 | New generation early diagnosis prostate gland cancer reagent kit and preparation method and detection process thereof |
| WO2009029550A2 (en) | 2007-08-24 | 2009-03-05 | Singulex, Inc. | Highly sensitive system and methods for analysis of prostate specific antigen (psa) |
| CN101377500A (en) | 2007-08-31 | 2009-03-04 | 北京科美东雅生物技术有限公司 | Free prostate gland specificity antigen chemiluminescence immune analysis determination reagent kit and preparing method thereof |
| US20110039284A1 (en) | 2007-10-22 | 2011-02-17 | Samuel Norbert Breit | Methods of prognosis |
| US20090226912A1 (en) | 2007-12-21 | 2009-09-10 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| JP5028697B2 (en) | 2008-02-18 | 2012-09-19 | 富士フイルム株式会社 | Suction syringe and endoscope suction syringe |
| WO2009138392A1 (en) | 2008-05-14 | 2009-11-19 | ETH Zürich | Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith |
| FR2934698B1 (en) | 2008-08-01 | 2011-11-18 | Commissariat Energie Atomique | PREDICTION METHOD FOR THE PROGNOSIS OR DIAGNOSIS OR THERAPEUTIC RESPONSE OF A DISEASE AND IN PARTICULAR PROSTATE CANCER AND DEVICE FOR PERFORMING THE METHOD. |
| AU2009308124B2 (en) | 2008-10-20 | 2014-12-11 | Liposcience, Inc. | Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same |
| US20110236903A1 (en) | 2008-12-04 | 2011-09-29 | Mcclelland Michael | Materials and methods for determining diagnosis and prognosis of prostate cancer |
| WO2010080115A2 (en) | 2008-12-18 | 2010-07-15 | Claros Diagnostics, Inc. | Improved reagent storage in microfluidic systems and related articles and methods |
| WO2010075446A1 (en) | 2008-12-23 | 2010-07-01 | Soar Biodynamics, Ltd. | Methods and systems for prostate health monitoring |
| US20120022793A1 (en) | 2009-01-19 | 2012-01-26 | Miraculins, Inc. | Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population |
| DE202010018623U1 (en) | 2009-02-02 | 2018-12-07 | Opko Diagnostics, Llc | Structures for controlling the light interaction with microfluidic devices |
| JP2010243406A (en) | 2009-04-08 | 2010-10-28 | F Hoffmann La Roche Ag | Method for detecting disease state progression degree of liver cancer and chronic liver disease using discriminant function characterized by measurement values of AFP and PIVKA-II |
| MX2011011571A (en) | 2009-05-01 | 2012-02-13 | Genomic Health Inc | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy. |
| CA2764049A1 (en) | 2009-06-04 | 2010-12-09 | Charite Universitaetsmedizin Berlin | Means and methods for diagnosing prostate carcinomas |
| WO2011027310A1 (en) | 2009-09-03 | 2011-03-10 | Koninklijke Philips Electronics N.V. | Novel tumor markers |
| WO2011027308A1 (en) | 2009-09-03 | 2011-03-10 | Koninklijke Philips Electronics N.V. | Novel tumor markers |
| KR101141190B1 (en) * | 2009-10-19 | 2012-06-13 | 중앙대학교 산학협력단 | Biomarker indicative of prostate cancer and diagnosis using the same |
| SA111320266B1 (en) * | 2010-03-11 | 2015-06-21 | رينات نيوروساينس كوربوريشن | Antibodies with pH Dependent Antigen Binding |
| AU2011239534B2 (en) | 2010-04-16 | 2015-01-22 | Opko Diagnostics, Llc | Feedback control in microfluidic systems |
| WO2012029080A1 (en) | 2010-08-30 | 2012-03-08 | Decode Genetics Ehf | Sequence variants associated with prostate specific antigen levels |
| BRPI1100857A2 (en) | 2011-03-18 | 2013-05-21 | Alexandre Eduardo Nowill | immunomodulatory agent and combinations thereof, their use and immunotherapeutic method for real time recontextualization, reprogramming and rebuilding of the immune system |
| US9594086B2 (en) | 2011-03-22 | 2017-03-14 | The Johns Hopkins University | Biomarkers for aggressive prostate cancer |
| WO2012170776A2 (en) | 2011-06-09 | 2012-12-13 | Quanterix Corporation | Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy |
| JP6072686B2 (en) | 2011-07-21 | 2017-02-01 | 和光純薬工業株式会社 | Standard solution for amino acid analysis in plasma |
| ES2601459T3 (en) | 2011-10-28 | 2017-02-15 | Fredax Ab | Therapeutic agents and uses thereof |
| US20150044666A1 (en) | 2012-01-13 | 2015-02-12 | Iris International Inc. | Non-equilibrium two-site assays for linear, ultrasensitive analyte detection |
| KR101933752B1 (en) | 2012-03-05 | 2018-12-28 | 오와이 아크틱 파트너스 에이비 | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| WO2013172779A2 (en) * | 2012-05-16 | 2013-11-21 | Phadia Ab | Method for indicating the presence or non-presence of prostate cancer |
| MX360236B (en) | 2012-06-27 | 2018-10-26 | Berg Llc | Use of markers in the diagnosis and treatment of prostate cancer. |
| CN102818892B (en) | 2012-08-16 | 2015-02-18 | 北京恩济和生物科技有限公司 | Detection kit for prostate specific antigen and preparation method thereof |
| US9175291B2 (en) | 2012-10-11 | 2015-11-03 | Isis Pharmaceuticals Inc. | Modulation of androgen receptor expression |
| RU2675370C2 (en) | 2012-11-20 | 2018-12-19 | Пхадиа Аб | Method for determining presence or absence of aggressive prostate cancer |
| JP2016508026A (en) | 2012-11-20 | 2016-03-17 | ファディア・アクチボラゲットＰｈａｄｉａ ＡＢ | Prognostic method for individuals with prostate cancer |
| DK3071595T3 (en) | 2013-11-19 | 2019-07-01 | Fredax Ab | HUMANIZED ANTI-CALLICINE-2 ANTIBODY |
| EP3117216B1 (en) | 2014-03-11 | 2023-01-11 | Phadia AB | Method for detecting a solid tumor cancer |
| US20170089904A1 (en) | 2014-03-28 | 2017-03-30 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| US10217619B2 (en) | 2015-03-12 | 2019-02-26 | Thermo Finnigan Llc | Methods for data-dependent mass spectrometry of mixed intact protein analytes |
| HUE055020T2 (en) | 2015-03-27 | 2021-11-29 | Opko Diagnostics Llc | Prostate antigen standards and uses thereof |
| CN107530412A (en) | 2015-04-29 | 2018-01-02 | 欧普科诊断有限责任公司 | For actively monitoring the composition and method of prostate cancer |
| US20190072555A1 (en) | 2017-08-14 | 2019-03-07 | Opko Diagnostics, Llc | Multiplex assays for evaluating prostate cancer status |
| WO2019221930A1 (en) | 2018-05-16 | 2019-11-21 | Opko Diagnostics, Llc | Methods for detecting prostate cancer pathology associated with adverse outcomes |
-
2015
- 2015-03-27 MX MX2016012667A patent/MX2016012667A/en unknown
- 2015-03-27 SG SG10201808585TA patent/SG10201808585TA/en unknown
- 2015-03-27 EP EP15768735.1A patent/EP3123381B1/en active Active
- 2015-03-27 CA CA2944001A patent/CA2944001C/en active Active
- 2015-03-27 KR KR1020167030100A patent/KR102505543B1/en active Active
- 2015-03-27 SG SG11201608035UA patent/SG11201608035UA/en unknown
- 2015-03-27 CN CN201580027646.1A patent/CN106663149A/en active Pending
- 2015-03-27 HU HUE15768735A patent/HUE065029T2/en unknown
- 2015-03-27 ES ES15768735T patent/ES2964706T3/en active Active
- 2015-03-27 DK DK15768735.1T patent/DK3123381T3/en active
- 2015-03-27 MY MYPI2016703503A patent/MY192513A/en unknown
- 2015-03-27 PT PT157687351T patent/PT3123381T/en unknown
- 2015-03-27 US US14/671,355 patent/US11761962B2/en active Active
- 2015-03-27 DE DE202015009668.9U patent/DE202015009668U1/en not_active Expired - Lifetime
- 2015-03-27 WO PCT/US2015/023096 patent/WO2015148979A1/en active Application Filing
- 2015-03-27 CN CN202210366591.9A patent/CN114740202A/en active Pending
- 2015-03-27 EP EP17187203.9A patent/EP3299977A1/en not_active Withdrawn
- 2015-03-27 JP JP2017502945A patent/JP6775488B2/en active Active
- 2015-03-27 BR BR112016022407A patent/BR112016022407A2/en active Search and Examination
- 2015-03-27 AU AU2015237270A patent/AU2015237270B2/en active Active
- 2015-03-27 PE PE2016001817A patent/PE20170298A1/en unknown
- 2015-03-27 TW TW104110105A patent/TWI687688B/en active
- 2015-03-27 EA EA201691952A patent/EA201691952A1/en unknown
- 2015-03-27 FI FIEP15768735.1T patent/FI3123381T3/en active
- 2015-03-27 PL PL15768735.1T patent/PL3123381T3/en unknown
- 2015-03-30 AR ARP150100936A patent/AR099883A1/en unknown
-
2016
- 2016-09-22 IL IL247981A patent/IL247981B/en active IP Right Grant
- 2016-09-27 MX MX2022002365A patent/MX2022002365A/en unknown
- 2016-09-27 CL CL2016002419A patent/CL2016002419A1/en unknown
-
2020
- 2020-10-06 JP JP2020169099A patent/JP7256781B2/en active Active
-
2021
- 2021-01-10 IL IL280039A patent/IL280039B/en unknown
-
2022
- 2022-10-27 JP JP2022172333A patent/JP7506131B2/en active Active
-
2023
- 2023-05-30 US US18/325,984 patent/US20230393137A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273090B (en) | Methods and compositions for the treatment of cancer | |
| IL247981A0 (en) | Compositions and methods related to diagnosis of prostate cancer | |
| EP3186393A4 (en) | Methods and compositions related to prostate cancer therapeutics | |
| HK1247931A1 (en) | Compositions and methods for diagnosis and treatment of cancer | |
| HK1211963A1 (en) | Compositions and methods for diagnosis and treatment of hepatic cancers | |
| ZA201701909B (en) | Trichoderma compositions and methods of use | |
| SG11201607795UA (en) | Inos-inhibitory compositions and their use as breast cancer therapeutics | |
| PL3200815T3 (en) | METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER | |
| SG11201701076TA (en) | Diagnosis of cancer | |
| EP2958591A4 (en) | Methods and compositions relating to the treatment of cancer | |
| IL259781A (en) | Uses of pyrimido-pyridazinones to treat cancer | |
| HK1243404A1 (en) | Tryptamide compositions and methods of use | |
| HK1213740A1 (en) | Methods of making cancer compositions | |
| ZA201506392B (en) | Compositions and methods including celecoxib and plumbagin relating to treatment of cancer | |
| GB201407837D0 (en) | Methods of cancer therapy | |
| TH1501005132A (en) | Composition and methods for diagnosis and treatment of liver cancer | |
| GB201410695D0 (en) | Uses of oligouronates in cancer treatment | |
| ZA201403006B (en) | Composition for use in treatment of cancer |